Company patents

Relign Corporation

Relign Corporation's patent strategy is almost exclusively focused on Medical Diagnostics & Surgery, representing 100.0% of its 48 patents. Surprisingly, despite this singular focus, patenting in this core area has seen a significant decline, with a -31.2% drop in 2025 and a -90.9% decrease so far in 2026, suggesting a potential shift away from active patenting in its primary domain.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

48 US filings (since 2023) · 3 categories · 3 themes

Patents

Showing 1-10 of 84

Page 1 of 9